4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001808968-26-000005
CHIEF EXECUTIVE OFFICER sold 8,165 shares at an average $77.15 ($629,895)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Klein Matthew B. · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-06 | Sale : show line 1 in the form 10b5-1 | −5,149 | $76.95 | $396,216 | 399,983 | D |
| 2026-01-07 | Sale : show line 2 in the form 10b5-1 | −3,016 | $77.48 | $233,680 | 396,967 | D |
| Open-market sales · 8,165 sh · avg $77.15 · $629,895 | ||||||
Loading xslF345X05/form4-01082026_050118.xml…